Live Breaking News & Updates on Pfizer Technology And
Stay updated with breaking news from Pfizer technology and. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Doctors can use it in an off label way, that offers a pathway to be able to give that third shot of pfizer to even moderna recipients. you have made things perfectly clear in a very complicated situation. so much,. have a great weekend. thank you. and senate majority leader chuck schumer is setting up procedural vote on monday on is resolution to fund the u.s. government and suspend the debt ceiling. that vote will come three days before the deadline to revert a government shutdown which could cost a lot of money and be unnecessary. senate republicans are vowing that they will only pass a stand alone short-term funding bill, and will not work with democrats to raise the debt limit. joining me now, the democratic senator from hawaii who serves also on the armed services committee. i want to ask you a quick question about that coming up. first of all, you ve got the deadline for the government running out of money completely ....
I also endorsed the recommendation to allow 18 to 49-year-olds with underlying medical conditions to receive a pfizer booster shot. these recommendations will help strengthen protection against severe disease in those populations who are at high risk of severe complications from covid-19. at the conclusion of the meeting the advisory committee had a robust discussion about whether boosters should be available for those at high risk of covid because of occupational or institutional risk. people like health care workers, teachers, frontline responders, essential workers and those in congregate settings. the result of their discussion was a close vote. had i been in the room and on the committee i would have voted yes and that is reflected in my resulting decision to allow the use of pfizer biontech covid-19 booster dose for those 18 and older at high risk of covid-19 exposure and transmission because of occupational and institutional exposure. ....
This has been a firing line. do you recommend to one of your high risk patients who had the moderna or j&j to get a pfizer booster or try to get moderna or whatever they ve got? no, listen, vice president harris is in that boat because of their exposure. she should get a booster. i do think these are perfectly good. i wouldn t begrudge my patients for waiting. i want them to get that booster now because we are watching that data for that frail population. we are hearing that moderna which has already filed that american application that should be getting progress in the next ....
Several weeks. the fda staff reiterated that as well. i would say wait but i m looking at nursing home patients. health care workers and others. i do think they should get a pfizer booster if they got moderna. i m in that category myself. would you only get pfizer or a third dose of moderna? the problem i would have we don t have if you re technically, just to be honest with you, moderna has filed for a reduced dose and there s a reason for that so i would be hesitant to say go out and get the third shot exactly like your first and second one. that tells me moderna has data we haven t seen it but caused them to reduce the dosage and recommendation possibly related to side effects, andrea. that s why saying that with pfizer where we know we have some data on the third shots and the moderna technology is similar to the pfizer technology and pfizer is fully approved so ....
Emergency use authorization of booster doses of the pfizer biontech vaccine. they met, as they often have during this pandemic, in a moment of great importance of health to many americans analyzing the complex real-time data available to make concrete recommendations. their task was not easy and their resulting hours long discussion reflected the tension of the moment between an individual calculation of risk and benefit and the impact on society. i listened intently to all of it. i heard a diversity of opinions and perspectives, and i applaud the committee s commitment to an open and transparent scientific process. following their vote, i fully endorsed acip, the committee s recommendations, that all people 65 and older and those 50 to 64 years old with underlying medical conditions should receive a pfizer booster shot if they received a pfizer primary series. ....